Background and Aims Liver disease remains a leading cause of morbidity and mortality
among people living with HIV (PLWH). Emerging data suggest that PLWH are at high risk for …

Following the Delphi consensus process, the term" steatotic liver disease"(SLD) was
introduced 28 to replace" fatty liver disease” while the term" metabolic dysfunction-associated …

6-Hydroxy-5,7,8-trimethyl-benzopyran derivatives and 5,7,8-trimethyl-1,4-benzoxazine
analogues substituted by the lidocaine pharmacophore aminoamide functionality at C4 or N4, …

Background Patients with multiple myeloma are at higher risk for infections due to disease
pathogenesis and administered therapies. The purpose of this study was to estimate the risk …

Novel hybrids of lipoic acid and trolox connected through triamine spacers as well as
analogues in which the lipoic acid was attached at different positions of the chroman moiety of …

In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced
hospitalization or death Page 1 In patients with COVID-19 at risk for severe disease, nirmatrelvir + …

Background: Biologic (bDMARD) and targeted synthetic (tsDMARD) disease-modifying anti-rheumatic
drugs have broadened the treatment options and are increasingly used for …

Introduction Rituximab and azathioprine are used to induce or maintain remission in patients
with ANCA-associated vasculitis (AAV). We evaluated the incidence of serious infections …

Non‐alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease. The
association between prior hepatitis B virus (HBV), hepatitis A virus (HAV), hepatitis E virus (…

Influenza infection is associated with cardiovascular complications that range significantly in
presentation and severity. The cumulative incidence of cardiovascular complications due to …